| pubmed-article:11092649 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11092649 | lifeskim:mentions | umls-concept:C0002965 | lld:lifeskim |
| pubmed-article:11092649 | lifeskim:mentions | umls-concept:C0206460 | lld:lifeskim |
| pubmed-article:11092649 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11092649 | lifeskim:mentions | umls-concept:C1305957 | lld:lifeskim |
| pubmed-article:11092649 | lifeskim:mentions | umls-concept:C1514983 | lld:lifeskim |
| pubmed-article:11092649 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11092649 | pubmed:dateCreated | 2000-11-28 | lld:pubmed |
| pubmed-article:11092649 | pubmed:abstractText | We sought to evaluate cardiac troponin I (cTnI) for predicting early clinical outcomes and the efficacy of enoxaparin among patients with non-ST segment elevation acute coronary syndrome (ACS) and negative creatine kinase, MB fraction (CK-MB) levels. | lld:pubmed |
| pubmed-article:11092649 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11092649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11092649 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11092649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11092649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11092649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11092649 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11092649 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11092649 | pubmed:issn | 0735-1097 | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:BraunwaldEE | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:AntmanE MEM | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:MorrowD ADA | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:McCabeC HCH | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:RifaiNN | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:CannonC PCP | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:TanasijevicMM | lld:pubmed |
| pubmed-article:11092649 | pubmed:author | pubmed-author:de LemosJ AJA | lld:pubmed |
| pubmed-article:11092649 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11092649 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:11092649 | pubmed:volume | 36 | lld:pubmed |
| pubmed-article:11092649 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11092649 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11092649 | pubmed:pagination | 1812-7 | lld:pubmed |
| pubmed-article:11092649 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:meshHeading | pubmed-meshheading:11092649... | lld:pubmed |
| pubmed-article:11092649 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11092649 | pubmed:articleTitle | Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. | lld:pubmed |
| pubmed-article:11092649 | pubmed:affiliation | Department of Medicine and Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. damorrow@bics.bwh.harvard.edu | lld:pubmed |
| pubmed-article:11092649 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11092649 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11092649 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11092649 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11092649 | lld:pubmed |
